Gynaecology News and Research

RSS

Artificial testes being developed to help infertile men produce sperm

Californian researchers are trying to create an artificial testicle that will produce human sperm. Dr. Paul Turek, director of the Turek Clinic in San Francisco, which specializes in male infertility, said the goal is not to create a testicular implant for men, but a “sperm-making biological machine” that will help scientists learn more about just what causes male infertility. “We’re trying to recreate the process of sperm production in a three-dimensional system,” Turek said. “Simple laboratory conditions can’t get it done in humans. Our concept is to actually recreate the testicle itself.”

22 Jan 2012

Number of unsafe abortions soars worldwide: Report

A new worldwide analysis by the Guttmacher Institute and the World Health Organization shows that unsafe abortions are on the rise across the world. After a period of significant decline in the global abortion rate as a whole, researchers found that those numbers had begun to plateau. The report was published in the Lancet.

22 Jan 2012

C-sections on the rise and most mothers not well informed: Queensland study

According to a latest study from Queensland, it is doctors, not mothers, who are responsible for the rising rate of babies born by caesarean section in Australia. Queensland has the highest rate of C-sections in Australia and researchers say often women are not properly informed when they make the decision to go ahead with surgery.

19 Jan 2012

Oral contraceptive pills help relieve period pain: Study

A three decade long study has proven that oral contraceptive pills may alleviate painful periods for some women. Estimates suggest more than half of women have suffered from the condition, called dysmenorrhea, at some point.

19 Jan 2012

Vinegar may easily detect cervical cancer

Vinegar may be more useful than realised. Its could offer the ability to find precancerous lesions in the cervix and potentially save thousands of women’s lives say researchers.

8 Jan 2012

Four or more coffees reduce risk of womb cancer

According to a new study drinking four or more cups of coffee a day may reduce risk of developing endometrial cancer or womb cancer by almost 25 per cent.

1 Jan 2012

Avastin fails to live up to expectations for extending survival in ovarian cancer

Cancer drug Avastin has been found to add about four months to the time it takes for the cancer to worsen for women with advanced cases of ovarian cancer says a new report. However it may not extend survival significantly.

29 Dec 2011

Scott & White gynecologist receives Honorary Fellowship from RANZCOG

Bob L. Shull, M.D., gynecologist and director of fellowship training in female pelvic medicine and reconstructive pelvic surgery at Scott & White Healthcare in Temple, Texas, has received an Honorary Fellowship from the Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

22 Dec 2011

Gynaecological cancer survival rates have improved in Eastern England

Gynaecological cancer survival rates have improved in Eastern England following the reorganisation of services and multidisciplinary team working finds a new study published in the gynaecological oncology themed issue of BJOG: An International Journal of Obstetrics and Gynaecology.

15 Dec 2011

Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC

Aeterna Zentaris Inc. today announced positive preclinical data in triple-negative breast cancer (TNBC) for its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131.

11 Dec 2011

King's College London submits first clinical grade xeno-free hES cell lines to the UKSCB

Stem cell scientists at King's College London will announce they have submitted to the UK Stem Cell Bank (UKSCB) their first clinical grade human embryonic stem (hES) cell lines that are free from animal-derived products, known as 'xeno-free' stem cells.

7 Dec 2011

Women experience intimate partner violence, depression after childbirth

Forty percent of women who report depressive symptoms following birth also reported intimate partner violence finds a new study published in BJOG: An International Journal of Obstetrics and Gynaecology.

7 Dec 2011

EpiGen to collaborate with Nestl- Research Center in Switzerland

The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.

23 Nov 2011

Coffee may protect against womb cancer: Study

For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.

22 Nov 2011

New breast and ovarian cancer vaccine in the pipeline: Study

A new vaccine is being tried clinically to combat tumor cells in a small study of advanced breast and ovarian cancer patients. The results show that there is improvement in overall survival times and stopping the disease for a handful of breast cancer patients.

8 Nov 2011

BMI, age are important risk factors for gestational diabetes mellitus

Age and body mass index (BMI) are important risk factors for gestational diabetes mellitus (GDM) particularly amongst South Asian and Black African women finds new research published in BJOG: An International Journal of Obstetrics and Gynaecology.

2 Nov 2011

Oral hormonal contraceptives linked to blood clots: Study

A new study has shown that women who use new type of contraceptive pills are twice as likely to develop life threatening blood clots as those who take older versions. Oral hormonal contraceptives have been known to increase the risk of a blood clot in deep leg veins, known as venous thromboembolism (VTE). These can prove fatal if they travel to the lungs. But, researchers at the University of Copenhagen, Denmark, found the “third-generation” pills are doubly harmful than the older versions.

30 Oct 2011